Neuroimmunology and Neuroinflammation
7 days Time toFirst Decision
42 days Submission toAcceptance
5 days Acceptance toPublication
About the journal
The journal focuses on neuroimmunology and neuroinflammation, and the coverage extends to other basic and clinical studies related to neuroscience, including molecular biology, psychology, pathology, physiology, endocrinology, pharmacology, oncology, etc. Articles of clinical interest and with clinical implications will be given preference. The journal specializes in the publication of articles dealing with epidemiological investigation and consensus guidelines and standards in the Asia-Pacific region. Articles in the following areas are especially welcome:
- Mechanisms of regulation of the immune and inflammatory response by the central nervous system;
- Changes in relevant immune and inflammatory reactions at the cellular and molecular level during the development of nervous system diseases;
- Clinical research on immune and inflammatory diseases of the nervous system.
The journal publishes the following types of articles: Original Article, Review, Guideline, Meta-Analysis, Systematic Review, Editorial, Case report, Commentary, etc. Manuscripts with videos are also welcome.
1 / 10
1260
Authors
260
Reviewers
2014
Published Since
Neuroimmunology and Neuroinflammation
Editors-in-Chief: Gang Zhao, Athanassios P. Kyritsis, Thomas Müller
Indexing: CAS, Wanfang Data, CNKI, Embase®
Median time to first editorial decision: 7 days
7 days Time to First Decision
42 days Submission to Acceptance
See More
Use of intravenous immunoglobulin to successfully treat COVID-19 associated encephalitis
Pathways linking Alzheimer's disease risk genes expressed highly in microglia
Intestinal inflammation and compromised barrier function in idiopathic parkinsonism: scenario captured by systematic review
Inflammation in the anterior visual pathway in multiple sclerosis: what do the animal models teach us?
1260
Authors
260
Reviewers
2014
Published Since













































































